Moleculin Announces New Investigator-Initiated Study of Annamycin for Treating Pancreatic Cancer
Moleculin Announces New Investigator-Initiated Study of Annamycin for Treating Pancreatic Cancer GlobeNewswire October 23, 2025 Atlantic Health, a leading provider of health care based in New Jersey, to conduct the investigator-initiated Phase 1B/2 study Preclinical studies indicate Annamycin targets key factors in pancreatic cancer HOUSTON, Oct. 23, 2025 (GLOBE NEWSWIRE) — Moleculin Biotech, Inc., (Nasdaq: […]